Opinion/decision on a Paediatric investigation plan (PIP): Mounjaro, Tirzepatide, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), PIP number: P/0033/2023

Opinion/decision on a Paediatric investigation plan (PIP): Vyvgart, Efgartigimod alfa, decision type: W: decision granting a waiver in all age groups for all conditions or indications, PIP number: P/0013/2023

List of signals discussed at PRAC since September 2012

New product information wording – Extracts from PRAC recommendations on signals adopted at the 8-11 January 2024 PRAC

PRIME: priority medicines

PRAC recommendations on signals adopted at the 8-11 January 2024 PRAC meeting

List of medicines currently in PRIME scheme

Recommendations on eligibility to PRIME scheme adopted at the CHMP meeting of 22-25 January 2024

Sixth EMA-Medicines for Europe bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 6 December 2023

Enpr-EMA newsletter 2023